11.   A. Well, from time to time, some people have called biotech stocks safe-haven stocks.

12.   But Chiron shares have fallen in recent months, amid a general decline for biotech stocks and concern about a forthcoming rival to its drug for multiple sclerosis.

13.   Chief Financial Officer James Persky attributes interest in his and other biotech stocks in large part to the dot-com fallout.

14.   Computer technology stocks may be near the end of their run, but biotech stocks look interesting.

15.   Despite record highs on Wall Street, most small and midsized biotech stocks have tanked as money managers shun long-term risks in biotech for instant riches on the Internet.

16.   Even expert investors get burned on biotech stocks because negative developments can pop out of nowhere.

17.   For all its recent woes, biotech stocks as a whole are still outperforming the broader markets.

18.   Genentech is not the only biotech stock to find favor on Wall Street of late.

19.   Hathaway typically buys biotech stocks when they are deeply out of favor.

20.   In general, biotech stocks rise when their products get approved by the FDA, and few observers doubt that Hextend will fail to pass muster with regulators.